Skip to content

Sex-related phenotypic differences in myotonic dystrophy types 1 and 2: a nationwide registry study from Serbia

Oct 2026 · Journal of Neurology · Vol 273 · 0 citations · 28 references
Medicine

TL;DR

It is found that sex is associated with distinct phenotypic profiles in DM1 and DM2, and male patients generally exhibit more cardiologic and endocrinological/metabolic burden in both DM1 and DM2.

View source

Similar papers

Review Aug 2026

Myotonic dystrophy type 1 - updates on mechanisms of multisystemic manifestations, genetically targeted therapeutics, and preparing for a postapproval world.

This review highlights genetically targeted therapeutics showing impact for muscle manifestations of DM1, ongoing efforts now shifting to expand to other target tissues and the younger population, and the understanding of societal burden and population genetics of DM1.

Samuel Carrell, Adam D. Comer, Nicholas E. Johnson · 1 citation
Open access 2026

Familial manifestation of limb-girdle muscular dystrophy associated with FKTN gene: a case report

Abstract Introduction: to report a familial case of Limb-girdle muscular dystrophy, type C, 4 (MDDGC4) associated with a homozygous mutation in FKTN gene, highlighting phenotypic variability, diagnostic delay, and atypical clinical features described in the pediatric literature. Description: two siblings were evaluated...

Milena Babugia Pinto, Fernanda Isabely Morgan Magalhães, V. T. Ebihara et al. · 0 citations
Review Open access Sep 2026

Cognitive decline over time in myotonic dystrophy type 1: a systematic review of longitudinal studies

Background Myotonic Dystrophy Type 1 (DM1) is a multisystem genetic disorder and the most common muscular dystrophy in adults. Central nervous system involvement is well-documented in DM1, including cognitive impairment. Cross-sectional studies have described a heterogeneous neuropsychological profile; however, the tra...

Ainara Clemente-Fernández, Irati Larrañaga, Joana Garmendia et al. · 0 citations
Review Open access Sep 2026

PREGNANCY IN MUSCULAR DYSTROPHIES: A NARRATIVE REVIEW OF CLINICAL RISKS, PHYSICAL ACTIVITY, AND MATERNAL-FETAL OUTCOMES

Introduction and purpose: Muscular dystrophies are progressive, hereditary muscle disorders whose inheritance pattern and multisystem involvement complicate reproductive decisions, yet evidence on maternal and neonatal outcomes remains fragmented. This review summarises current literature on pregnancy in women with dys...

Maria Całusińska-Skowron, Klaudia Jeziorowska, A. Kudłacik et al. · 0 citations
Open access Aug 2026

Clinical and Genetic Spectrum of ATP1A3-Related Disorders

The results highlight the need for a unified diagnostic framework for ATP1A3-related disorders and demonstrate the feasibility and scientific value of coordinated rare disease research in resource-limited settings.

Victor Rebelo Procaci, Raphael Pinheiro Camurugy da Hora, Anna Maria Gomes et al. · 0 citations
Open access Sep 2026

A Registry-Based Perspective of Interventional Clinical Trials for Duchenne Muscular Dystrophy

Background and objective Duchenne muscular dystrophy (DMD) is a severe, progressive, X-linked genetic disorder caused by pathogenic variants in the dystrophin gene, leading to progressive muscle weakness, loss of ambulation, and premature mortality. Clinical trials are essential for advancing evidence-based management...

J. H. Chaudhary, Jiya O. Chacko, Viswabhaskar Susarla et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.